Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23 EUR | +0.88% |
|
-4.96% | -20.14% |
28/06 | Would you like some more inflation? | ![]() |
28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
- Stock Market
- Equities
- GMAB Stock
- GE91 Stock
- News Genmab A/S
- Press Releases